ALAUNOS THERAPEUTICS INC (TCRT)

US98973P2002 - Common Stock

1.29  +0.03 (+2.38%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

 2023
(2023-12-31)		 2022
(2022-12-31)		 2021
(2021-12-31)		 2020
(2020-12-31)		 2019
(2019-12-31)
ASSETS
Current Assets
Cash Equivalents
6.06M39.10M76.10M115.10M79.70M
Receivables
1.00K0.001.10M4.70M3.30M
Other Current Assets
2.20M14.70M1.70M10.90M22.40M
Total Current Assets
8.26M53.80M78.80M130.60M105.50M
 
Non-Current Assets
PPE Net
2.00K10.60M15.40M14.90M3.40M
Other Non-Current Assets
0.00500.00K700.00K900.00K200.00K
Total Non-Current Assets
2.00K11.10M16.10M15.70M3.60M
 
TOTAL ASSETS
8.26M64.90M94.90M146.30M109.10M
 
LIABILITIES
Current Liabilities
Short Term Debt
0.000.000.000.000.00
Current Portion Of LT Debt.
0.0016.80M7.90MN/AN/A
Accrued Expenses
1.34M6.00M6.80M17.40M11.60M
Accounts Payable
616.00K1.40M1.40M1.00M900.00K
Other Current Liabilities
N/AN/AN/AN/AN/A
Total Current Liabilities
1.96M24.20M16.00M18.40M12.50M
 
Non-Current Liabilities
Long Term Debt
0.000.0016.30M0.000.00
Other Non-Current Liabilities
0.002.20M4.50M4.00M1.60M
Total Non-Current Liabilities
0.002.20M20.80M4.00M1.60M
 
TOTAL LIABILITIES
1.96M26.40M36.80M22.40M14.10M
 
SHAREHOLDERS' EQUITY
Retained Earnings
-915.77M-880.60M-842.90M-764.10M-684.10M
Additional Paid In Capital
922.06M918.90M900.70M887.90M779.00M
Common Shares
16.00K200.00K200.00K200.00K200.00K
Shares Outstanding
16.01M240.40M216.10M214.60M181.80M
Tangible Book Value per Share
0.390.160.270.580.52
Total Shareholders' Equity
6.31M38.60M58.10M124.00M95.00M
 
TOTAL LIABILITIES AND EQUITY
8.26M64.90M94.90M146.30M109.10M
 
Statistics
Debt/Equity
N/AN/A0.28N/AN/A
Current Ratio
4.222.224.927.108.44
Return On Assets (ROA)
-425.27%-58.14%-82.98%-54.67%-107.97%
Return On Equity (ROE)
-557.16%-97.75%-135.54%-64.50%-124.00%

All data in USD

Charts